Rosenblatt Re-Rates Imax As Jurassic World Dominion Continues To Rule Charts

Rosenblatt analyst Steve Frankel reiterated a Buy rating on Imax Corp IMAX with a price target of $25.

Jurassic World Dominion raked $58.7 million in its second weekend, beating Lightyear to lead the domestic box office. 

To date, Dominion has earned $259 million. With a three-day opening of $51 million, Lightyear missed industry expectations of $70 million - $85 million. 

Top Gun: Maverick added $44 million to push its domestic total to $461 million. Overseas, Lightyear grossed a disappointing $34.6 million from 43 markets. 

Meanwhile, Jurassic World: Dominion added another $76.1 million to bring its international total to $372.4 million ($622.2 million globally), owning the winner's mantle in China, earning $92.8 million so far.

Top Gun: Maverick earned $39.7 million, bringing the international total to $419 million and $885 million globally, making it Tom Cruise's best-selling film.

IMAX dedicated most of its domestic capacity to Dominion, except for matinee showings of Lightyear. As a result, Imax accounted for 8% of Dominion's weekend for $4.6 million in GBO, bringing the film's domestic total to $20.5 million. 

Overseas, Dominion generated another $4.2 million in GBO, bringing the international GBO total to $20.9 million, including $9.9 million from China.

Lightyear added $1.7 million in GBO, with $1.1 million coming from domestic screens, and Top Gun: Maverick generated $2.1 million in international GBO to bring the film's global total to $79 million.

Price Action: IMAX shares traded higher by 1.6% at $15.21 on the last check Tuesday.

Photo via Wikimedia Commons

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorNewsPrice TargetReiterationSmall CapAnalyst RatingsTech
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!